Bioseeker, Feb 2011
according to country of investigator.
Drug name & Synonyms
Lists commercial, generic and code names for drugs.
Developmental stage
This DrugPipelineUpdate contains 331 (280) leukemiadrugs in development
Life Science Analytics, March 2011, Pages: 1418
Leukemia and Types of Leukemia Therapy Area Pipeline Report contains detailed information on the leukemia and types of leukemiadrugpipeline. This report provides insight into the pipeline status
Bioseeker, April 2011 PipelineUpdate 2011-.
The Package Includes:
- A progress analysis on current and emerging drugs
- Information on most companies active in leukemia R&D
- Information on key industry related leukemia
Global Markets Direct, Dec 2010, Pages: 27
milestones.
- Recent updates of the Northern Italy Leukemia Group’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
Global Markets Direct, Dec 2010, Pages: 35
Advances in Childhood Leukemia Consortium human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug
Global Markets Direct, Oct 2011, Pages: 160
Lymphocytic Leukemia (CLL) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with latest updates, and special features
Global Markets Direct, Dec 2010, Pages: 128
Leukemia therapeutic pipeline. This report provides information on the therapeutic development for Chronic Myelocytic Leukemia, complete with latest updates, and special features on late-stage
Global Markets Direct, Oct 2011, Pages: 123
Myelocytic Leukemia (CML) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Myelocytic Leukemia (CML), complete with latest updates, and special features on late
GlobalData, Dec 2010, Pages: 56
and major milestones.
- Recent updates of Japan Adult Leukemia Study Group’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug
Global Markets Direct, March 2011, Pages: 55
- Identify new drug targets and therapeutic classes in Japan Adult Leukemia Study Group’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing
Global Markets Direct, Dec 2010, Pages: 56
- Identify new drug targets and therapeutic classes in Japan Adult Leukemia Study Group’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing
Global Markets Direct, March 2011, Pages: 130
Myelocytic Leukemia (CML) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Myelocytic Leukemia (CML), complete with latest updates, and special features on late
Global Markets Direct, Dec 2010, Pages: 158
Lymphocytic Leukemia therapeutic pipeline. This report provides information on the therapeutic development for Chronic Lymphocytic Leukemia, complete with latest updates, and special features on late-stage
Bioseeker, Sep 2007, Pages: 500
Stage Pipeline
9.5 Drugs Soon to be on the Market
9.6 Approved Drugs
10 Leukemia: An Introduction
10.1 Leukemia Disease Definitions
10.1.1 The Lymphoid Malignancies
10.1.2 The Myeloid Malignancies
Bioseeker, Dec 2007, Pages: 430
type, Targets & Mechanisms
16 Competitive Landscape in LeukemiaDrug Development: The Late Stage Pipeline
16.1 The Lymphoid Malignancies
16.2 The Myeloid Malignancies
17 Current LeukemiaDrug
Bioseeker, Feb 2011
- Where to Commercialize?
Protein Kinase Inhibitors in Oncology: DrugPipelineUpdate 2011-
The Package Includes
- A progress analysis on current and emerging drugs
- Information on most companies active
Global Markets Direct, March 2011, Pages: 167
Lymphocytic Leukemia (CLL) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with latest updates, and special features
Global Markets Direct, March 2011, Pages: 220
Leukemias - Pipeline Review, Q1 2011
Summary
Global Markets Direct’s, 'Leukemias - Pipeline Review, Q1 2011', provides an overview of the Leukemias therapeutic pipeline. This report provides
